Evidence map›Paper›PMID 39833938›Full record

ArticleBMC medical genomics2025

Genomic detection of Panton-Valentine Leucocidins encoding genes, virulence factors and distribution of antiseptic resistance determinants among Methicillin-resistant S. aureus isolates from patients attending regional referral hospitals in Tanzania.

Masoud A Juma, Tolbert Sonda, Boaz Wadugu, Davis Kuchaka, Mariana Shayo, Petro Paulo, Patrick Kimu, Livin E Kanje, Melkiory Beti, Marco Van Zwetselaar and 2 more

Abstract read
In one paragraph

Article in BMC medical genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Point of care antimicrobial susceptibility testing.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Masoud A JumaKilimanjaro Christian Medical University College, Kilimanjaro, Tanzania. sallass2012@gmail.com.
Tolbert SondaKilimanjaro Christian Medical University College, Kilimanjaro, Tanzania.
Boaz WaduguKilimanjaro Clinical Research Institute, Kilimanjaro, Tanzania.
Davis KuchakaKilimanjaro Clinical Research Institute, Kilimanjaro, Tanzania.
Mariana ShayoKilimanjaro Christian Medical University College, Kilimanjaro, Tanzania.
Petro PauloKilimanjaro Christian Medical University College, Kilimanjaro, Tanzania.
Patrick KimuKilimanjaro Clinical Research Institute, Kilimanjaro, Tanzania.
Livin E KanjeKilimanjaro Christian Medical University College, Kilimanjaro, Tanzania.
Melkiory BetiKilimanjaro Clinical Research Institute, Kilimanjaro, Tanzania.
Marco Van ZwetselaarKilimanjaro Clinical Research Institute, Kilimanjaro, Tanzania.
Blandina MmbagaKilimanjaro Christian Medical University College, Kilimanjaro, Tanzania.
Happiness KumburuKilimanjaro Christian Medical University College, Kilimanjaro, Tanzania.

Funding

Danida Fleming Fund DFC No. 20-12-TAN
6 · The paper itself

Abstract

backgroundMethicillin-resistant Staphylococcus aureus (MRSA) is a formidable public scourge causing worldwide mild to severe life-threatening infections. The ability of this strain to swiftly spread, evolve, and acquire resistance genes and virulence factors such as pvl genes has further rendered this strain difficult to treat. Of concern, is a recently recognized ability to resist antiseptic/disinfectant agents used as an essential part of treatment and infection control practices. This study aimed at detecting the presence of pvl genes and determining the distribution of antiseptic resistance genes in Methicillin-resistant Staphylococcus aureus isolates through whole genome sequencing technology. MATERIALS AND

methodsA descriptive cross-sectional study was conducted across six regional referral hospitals-Dodoma, Songea, Kitete-Kigoma, Morogoro, and Tabora on the mainland, and Mnazi Mmoja from Zanzibar islands counterparts using the archived isolates of Staphylococcus aureus bacteria. The isolates were collected from Inpatients and Outpatients who attended these hospitals from January 2020 to Dec 2021. Bacterial analysis was carried out using classical microbiological techniques and whole genome sequencing (WGS) using the Illumina Nextseq 550 sequencer platform. Several bioinformatic tools were used, KmerFinder 3.2 was used for species identification, MLST 2.0 tool was used for Multilocus Sequence Typing and SCCmecFinder 1.2 was used for SCCmec typing. Virulence genes were detected using virulenceFinder 2.0, while resistance genes were detected by ResFinder 4.1, and phylogenetic relatedness was determined by CSI Phylogeny 1.4 tools.

resultsOut of the 80 MRSA isolates analyzed, 11 (14%) were found to harbor LukS-PV and LukF-PV, pvl-encoding genes in their genome; therefore pvl-positive MRSA. The majority (82%) of the MRSA isolates bearing pvl genes were also found to exhibit the antiseptic/disinfectant genes in their genome. Moreover, all (80) sequenced MRSA isolates were found to harbor SCCmec type IV subtype 2B&5. The isolates exhibited 4 different sequence types, ST8, ST88, ST789 and ST121. Notably, the predominant sequence type among the isolates was ST8 72 (90%).

conclusionThe notably high rate of antiseptic resistance particularly in the Methicillin-resistant S. aureus strains poses a significant challenge to infection control measures. The fact that some of these virulent strains harbor the LukS-PV and LukF-PV, the pvl encoding genes, highlight the importance of developing effective interventions to combat the spreading of these pathogenic bacterial strains. Certainly, strengthening antimicrobial resistance surveillance and stewardship will ultimately reduce the selection pressure, improve the patient's treatment outcome and public health in Tanzania.

Indexed as

Bacterial ToxinsExotoxinsLeukocidinsMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsVirulence FactorsAnti-Infective Agents, LocalCross-Sectional StudiesHumansMicrobial Sensitivity TestsReferral and ConsultationTanzaniaWhole Genome SequencingAnti-Infective Agents, LocalBacterial ToxinsExotoxinsLeukocidinsPanton-Valentine leukocidinVirulence FactorsMethicillin-resistant S. aureus (MRSA)Panton valentine leucocidin (pvl)Quaternary ammonium compounds (Qac)Sequence type (ST)

Identifiers

PMID39833938
PMCPMC11748250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.